Disperazol joins the AMR Industry Alliance

We are excited to have joined the AMR Industry Alliance. The team at Disperazol has more than 40 years of experience across fundamental research and translational development of antibacterial compounds. We are pleased to be able to join our global partner organisations in the AMR Industry Alliance to co-create new ways of working that will help to overcome the scientific challenges of creating new antimicrobials and taking these to market.

We recognise that there are both challenges and opportunities for development of new antibiotics and novel antimicrobials and look are looking forward to being able to play our part in bringing some of these to life.